Read More

Cannabis Found Less Harmful Than Alcohol In New Study: Where Is The Demand Heading? Investor Market Tips

A recent study led by Dr. Erika Rosen of the Alcohol Research Group and RTI International and published in the Journal of Studies on Alcohol and Drugs, explores the differential impacts of alcohol, cannabis, and opioids on U.S. adults.

STZ

Read More

Canopy Growth’s Big Step Toward Entry Into US Cannabis Market As DEA Rescheduling Looms

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) said that in connection with the creation of the company's non-voting and non-participating exchangeable shares, on Thursday, April 18, Greenstar Canada Investment Limited Partnership and CBG Holdings LLC, each a wholly-owned subsidiary of Constellation Brands Inc (NYSE: STZ) exchanged all 17,149,925 common shares in the capital of the company they collectively held for 17,149,925 exchangeable shares for no consideration. The CBG Group no longer holds any common shares of Canopy, as a result, the company said on Thursday. In connection with the termination of the investor rights agreement between CBG, Greenstar and Canopy Growth, the parties entered earlier and following the note exchange, Garth Hankinson, Judy Schmeling and James Sabia each provided notice to the company of his or her decision to resign from the board.

CGC

Read More

Cheers to Growth: Constellation Brands Gets Upgrade, Analyst Bullish on Beer Sales

Constellation Brands gets a Buy rating upgrade from Argus Research analyst John Staszak, with a bullish price target of $306. Fiscal Q4 2024 saw a 7% rise in comparable sales to $2.14 billion, surpassing estimates. Beer revenue surged by approximately 11%, boosting overall sales, leading to an optimistic EPS outlook for FY25 and FY26.

STZ